—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Roivant Sciences Ltd (ROIV) — Technical state

As of 2026-11-10 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 38 out of 100 (momentum 91 · quality 21 · valuation 37), as of 2026-11-11.
  • Signal: Uptrend stack intact — Trades +11.5% vs the 50-day and +28.6% vs the 200-day average, 3.1% below the 52-week high and +108.1% off the 52-week low. Computed from daily closes. (as of 2026-11-10)
  • Trend: Roivant Sciences Ltd trades 11.5% above its 50-day and 28.6% above its 200-day moving average. (as of 2026-11-10)

Roivant Sciences discovers, develops and aims to commercialise new medicines, mainly in autoimmune and cardiopulmonary disease. Its pipeline includes antibody and small-molecule candidates for conditions such as pulmonary hypertension, thyroid eye disease and several IgG-mediated autoimmune disorders, alongside lipid-nanoparticle and ligand-conjugate delivery platforms.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ROIV overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +11.5% vs the 50-day and +28.6% vs the 200-day average, 3.1% below the 52-week high and +108.1% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ROIV chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-10

Quick answers

What is the current Closelooknet signal on ROIV?

Uptrend stack intact — Trades +11.5% vs the 50-day and +28.6% vs the 200-day average, 3.1% below the 52-week high and +108.1% off the 52-week low. Computed from daily closes. As of 2026-11-10; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ROIV above its 50-day and 200-day moving averages?

As of 2026-11-10, Roivant Sciences Ltd trades +11.5% above its 50-day and +28.6% above its 200-day average, with the 20-day +12.4% away.

How far is ROIV from its 52-week high?

3.1% below the 52-week high and 108.1% above the 52-week low, as of 2026-11-10.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.